Serum Amyloid A and C-Reactive Protein Independently Predict the Recurrences of Atrial Fibrillation After Cardioversion in Patients With Preserved Left Ventricular Function

Canadian Journal of Cardiology

Volumn 28, Issue 5, 2012, Pages 537-541

  Barassi, Alessandra ^a   Pezzilli, Raffaele ^b   Morselli Labate, Antonio M ^b   Lombardi, Federico ^a   Belletti, Sebastiano ^a   Dogliotti, Giada ^a   Corsi, Massimiliano M ^a,c   Merlini, Giampaolo ^d   Melzi D'Eril, Gian Vico ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c IRCCS POLICLINICO SAN DONATO   (Italy)

^d UNIVERSITY OF PAVIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; SERUM AMYLOID A;

ADULT; AGED; ARTICLE; CARDIOVERSION; DIABETES MELLITUS; DISEASE DURATION; FEMALE; HEART ATRIUM FIBRILLATION; HEART HEMODYNAMICS; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; PHYSICAL EXAMINATION; RECURRENCE RISK; RECURRENT DISEASE; RELAPSE; SENSITIVITY AND SPECIFICITY; SINUS RHYTHM; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TRANSTHORACIC ECHOCARDIOGRAPHY;

AGED; ANALYSIS OF VARIANCE; ATRIAL FIBRILLATION; C-REACTIVE PROTEIN; COHORT STUDIES; CONFIDENCE INTERVALS; ELECTRIC COUNTERSHOCK; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; INFLAMMATION MEDIATORS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NATRIURETIC PEPTIDE, BRAIN; ODDS RATIO; PEPTIDE FRAGMENTS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; RECURRENCE; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SERUM AMYLOID A PROTEIN; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE; VENTRICULAR FUNCTION, LEFT;

EID: 84866422681     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cjca.2012.02.014     Document Type: Article

References (21)

1. Allessie M.A., Boyden P.A., Camm A.J., et al. Pathophysiology and prevention of atrial fibrillation. Circulation 2001, 103:769-777.
2. Allessie M.A., Ausma J., Schotten U. Electrical, contractile, and structural remodeling during atrial fibrillation. Cardiovasc Res 2002, 54:230-246.
3. Nattel S. From guidelines to bench: implications of unresolved clinical issue for basic investigations of atrial fibrillation mechanisms. Can J Cardiol 2011, 27:19-26.
4. Healey J.S., Parkash R., Pollak T., Tsang T., Dorian P. Canadian Crdiovascular Society Atrial Fibrillation Guidelines 2010: etiology and initial investigations. Can J Cardiol 2011, 27:31-37.
5. Frustaci A., Chimenti C., Bellocci F., et al. Histological substrate of atrial biopsies in patients with lone atrial fibrillation. Circulation 1997, 96:1180-1184.
6. Bruins P., te Velthuis H., Yazdanbakhsh A.P., et al. Activation of the complement system during and after cardiopulmonary bypass surgery: postsurgery activation involves C-reactive protein and is associated with postoperative arrhythmia. Circulation 1997, 96:3542-3548.
7. Chung M.K., Martin D.O., Sprecher D., et al. C-reactive protein elevation in patients with atrial arrhythmias: inflammatory mechanisms and persistence of atrial fibrillation. Circulation 2001, 104:2886-2891.
8. Aviles R.J., Martin D.O., Apperson-Hansen C., et al. Inflammation as a risk factor for atrial fibrillation. Circulation 2003, 108:3006-3010.
9. Psychari S.N., Apostolou T.S., Sinos L., et al. Relation of elevated C-reactive protein and interleukin-6 levels to left atrial size and duration of episodes in patients with atrial fibrillation. Am J Cardiol 2005, 95:764-767.
10. Dernellis J., Panaretou M. Relationship between C-reactive protein concentrations during glucocorticoid therapy and recurrent atrial fibrillation. Eur Heart J 2004, 25:1100-1107.
11. Conway D.S., Buggins P., Hughes E., Lip G.Y. Predictive value of indexes of inflammation and hypercoagulability on success of cardioversion of persistent atrial fibrillation. Am J Cardiol 2004, 94:508-510.
12. Malouf J.F., Kanagala R., Al Atawi F.O., et al. High sensitivity C-reactive protein: a novel predictor for recurrence of atrial fibrillation after successful cardioversion. J Am Coll Cardiol 2005, 46:1284-1287.
13. Wazni O., Martin D.O., Marrouche N.F., et al. C-reactive protein concentration and recurrence of atrial fibrillation after electrical cardioversion. Heart 2005, 91:1303-1305.
14. Nattel S. New ideas about atrial fibrillation 50 years on. Nature 2002, 415:219-226.
15. Korantzopoulos P., Kolettis T.M., Goudevenos J.A., Siogas K. Errors and pitfalls in the non-invasive management of atrial fibrillation. Int J Cardiol 2005, 104:125-130.
16. Lombardi F., Tundo F., Belletti S., Mantero A., Melzi d'Eril G.V. C-reactive protein but not atrial dysfunction predicts recurrences of atrial fibrillation after cardioversion in patients with preserved left ventricular function. J Cardiovasc Med 2008, 9:581-588.
17. Pezzilli R., Billi P., Miniero R., et al. Serum interleukin-6, interleukin-8, and beta 2-microglobulin in early assessment of severity of acute pancreatitis. Comparison with serum C-reactive protein. Dig Dis Sci 1995, 40:2341-2348.
18. Lachmann H.J., Goodman H.J., Gilbertson J.A., et al. Natural history and outcome in systemic AA amyloidosis. N Engl J Med 2007, 356:2361-2371.
19. Sipe J.D., Benson M.D., Buxbaum J.N., et al. Amyloid fibril protein nomenclature: 2010 recommendations from the nomenclature committee of the International Society of Amyloidosis. Amyloid 2010, 17:101-104.
20. Goette A., Bukowska A., Lendeckel U., et al. Angiotensin II receptor blockade reduces tachycardia-induced atrial adhesion molecule expression. Circulation 2008, 117:732-742.
21. Hammwöhner M., Ittenson A., Dierkes J., et al. Platelet expression of CD40/CD40 ligand and its relation to inflammatory markers and adhesion molecules in patients with atrial fibrillation. Exp Biol Med 2007, 232:581-589.